Weekly low-dose semaglutide for alcohol use disorderU.S. study suggests that semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, may be useful to reduce alcohol consumption and craving in alcohol use disorder. ‘Like a switch you can turn off’: Pain medication shown to reduce toxins from kidney diseaseA low dosage of mefenamic acid, an anti-inflammatory drug, can potentially reduce a toxic compound in people with kidney disease, according to a study. POP QUIZ: Insujet: No-needle insulin administration device InsuJet, the first needleless device for insulin delivery, is now available in Canada. Can you tell which statement about this device is false? Health Canada’s updated requirements for drug and medical device recalls In December, Health Canada published regulations amending the current guidance pertaining to recalls of food, drugs and medical devices. Semaglutide and tirzepatide possibly associated with ophthalmic complications Case series describes the rare development of nonarteritic anterior ischemic optic neuropathy (NAION) in new users of semaglutide or tirzepatide. Plecanatide approved as a new option for chronic idiopathic constipation in adults Trulance (plecanatide) is now indicated for the treatment of chronic idiopathic constipation in adults. Can infrequent zoledronate dosing in early postmenopause prevent fractures? Study examines zoledronate dosing at baseline and at five years to determine effects on vertebral fracture prevention in early postmenopausal women. NDSAC releases final recommendations for cetirizine in children Effective Jan. 21, pharmacists should take note of these recommendations for cetirizine or its salts. POP QUIZ: Constella for constipation in children Constella (linaclotide) capsules were recently approved by Health Canada for use in children with constipation. New guidance on caring for newborns at risk of withdrawal due to parental substance use The Canadian Pediatric Society provides updated evidence-based advice as incidence of neonatal abstinence syndrome is rising. 1 2 3 4 5 Next Last
